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Background
Cardiac resynchronization therapy (CRT) aims to reduce
dyssynchronous contraction through simultaneous
pacing of the right ventricular (RV) septum and left ven-
tricular (LV) lateral wall. Up to 40% of patients do not
respond, largely attributed to lack of dysynchrony and/
or transmural scar at pacing sites. In this pilot study we
tested the feasibility of guiding LV and RV leads to
“optimal” segmental targets using a MRI-based 3D sur-
face rendered cardiac model.
Methods
Ten consecutive patients planned for CRT were
recruited. All patients underwent cardiac MRI inclusive
of cine and delayed enhancement (DE) imaging using a
3T scanner. A blinded interpreter determined the time
to maximal radial wall thickening (TmWT) and myocar-
dial scar burden for each of 16 segments. All potential
LV lead targets were ranked according to scar burden
(lowest first) and then sub-ranked by TmWT (highest
first). All potential RV lead targets were ranked accord-
ing to scar burden (lowest first). These rankings were
encoded onto a surface rendered cardiac model, dis-
played in standard fluoroscopic views (Figure 1A) and
used to direct lead placement by fluoroscopy. A cardiac
gated CT was then performed at a 1-month follow-up
visit (Figure 1B) to assess procedural success for target
achievement.
Results
Mean age and LVEF was 68.5 ±6.7 years and 25.6
±10.8%, with a mean NYHA class of 2.9 ± 0.6. “Opti-
mal” LV and RV pacing sites differed from conventional
pacing sites (basal posterolateral segment and RV apex)
in 9 and 4 patients, respectively. All patients successfully
underwent CRT device implantation with a mean
fluoroscopy time of 23 ± 10.9 minutes. Post-device CT
imaging showed LV and RV leads to be successfully
delivered to the “optimal” or immediately adjacent seg-
ment in 90% and 90% of patients, respectively. The only
documented complication was a small pericardial effu-
sion not requiring drainage in a patient that was pre-
scribed conventional lead positioning by the model.
Conclusions
In this pilot study we demonstrate that a targeted
approach to CRT lead placement using an MRI-based
cardiac model is clinically feasible. A prospective clinical
trial evaluating the clinical benefit of this approach is
planned.
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